Trial
NCT04418661
Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
Revolution Medicines, Inc.; Mirati Therapeutics Inc.
Condition
Metastatic Neoplasm
Intervention
Vociprotafib
Why stopped
Sponsor's decision not related to any safety concern
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-29